Verified stock metrics
Inhibikase Therapeutics Key Stock Metrics
Inhibikase Therapeutics (IKT) market cap, valuation, profitability and growth m…
Direct answer
Inhibikase Therapeutics has 5 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 31, 2026.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $322.33M
- Price-to-book ratio
- 2.63x
- Return on equity
- -51.96%
- 52-week price range
- $1.33 to $2.54
- Profit margin
- 0%